Liraglutide 3.0 mg as an Adjunct to Intensive Behavior Therapy in Individuals with Obesity: SCALE IBT 56-Week Randomized, Double-Blind, Placebo-Controlled Trial

Source: Wadden T, Tronieri JS, Sugimoto D, et al. SAT-099 Liraglutide 3.0 mg as an Adjunct to Intensive Behavior Therapy in Individuals with Obesity: SCALE IBT 56-Week Randomized, Double-Blind, Placebo-Controlled Trial. Journal of the Endocrine Society, 30 April 2019, DOI:10.1210/js.2019-SAT-099

Please sign in or register for FREE

No comments yet.